Personalised telehealth intervention for chronic disease management: A pilot randomised controlled trial.
Source: Bohingamu Mudiy-anselage, S., et al. 2019 - Pubmed ID: 29793387
Setting: Australia, Regional health service center
RCT
Follow up: 12 months
Sample size:
Total: 177 (163)
IG: 88 (83)
CG: 89(80)
Inclusion criteria:
– Diabetes and/or chronic obstructive pulmonary disease (COPD)
– high risk for readmission
Home monitoring equipment:
– tablet
– peripheral monitoring equipment
Videoconsultation
– health coaching
Technology platform:
– Remote Patient Monitoring from TELUS®
Intervention:
– Pt collect biometric readings and enter daily answers to health questionnaire
– Nurses and specialist consultant provide an individualized care plan with upper and lower limits on individual parameters.
-Nurses identify when data are outside threshold and respond to pt.
Duration: 12 months
Add on: NA
Control group:
Usual care
Clinical effect (for both diabetes and COPD and both) :
– Bp →
– HbA1c →
– Total cholesterol →
– Triglyceride →
– Microalbumin ↓
– GAD-7, anxiety↓(improved)
– PHQ-9 depression ↓(improved)
– health literacy domains (HeiQ): 4/8 domains ↑ (improvement)
4/8 domains →
Patient safety:
NA
Patient experiences: NA
Staff experiences: NA
Investment:
Material:
– monitoring equipment
– Remote Patient Monitoring platform from TELUS®
Running:
Staff resources
– Monitoring patient data
– on call staff
– pt. coaching sessions
Organization:
Written or telephone contact with primary care (GP)
Health care utilization:
– Hospital admissions →
– mean hospital length of stay → (acute admissions ↓)
– mean hospital cost ↓